Hypercoagulability Due to COVID-19 Leading to Impending Phlegmasia Cerulea Dolens and Sub-Massive Bilateral Pulmonary

Bruno Moraes1, Amir Hashemi1, Kevin Mancheno2

  • 1Emergency Medicine, Graduate Medical Education, Aventura Hospital and Medical Center, Aventura, USA.

Cureus
|September 27, 2021
PubMed

Insights

A COVID-19 patient developed severe leg clots extending to the inferior vena cava (IVC), leading to a pulmonary embolism. Prompt interventional treatment resulted in a stable recovery.

Area of Science:

  • Vascular Medicine
  • Infectious Disease
  • Interventional Radiology

Background:

  • Coronavirus disease 2019 (COVID-19) is associated with hypercoagulable states.
  • Venous thromboembolism is a known complication of COVID-19.

Observation:

  • A 47-year-old male with hypertension and pre-diabetes presented with acute dyspnea and unilateral leg swelling post-COVID-19 infection.
  • Clinical examination and ultrasound revealed extensive deep and superficial lower extremity venous thrombosis extending to the inferior vena cava (IVC).
  • The patient was diagnosed with impending phlegmasia cerulea dolens and showed signs suggestive of pulmonary embolism on V/Q scan.

Findings:

  • Extensive lower extremity deep vein thrombosis (DVT) and superficial venous thrombosis involving the inferior vena cava (IVC).
  • Widespread ventilation/perfusion (V/Q) mismatch indicating pulmonary embolism.
  • Successful management with catheter-directed alteplase and IVC filter placement.

Implications:

  • This case highlights the potential for severe venous thromboembolism in COVID-19 patients.
  • Early recognition and aggressive interventional management are crucial for favorable outcomes.
  • Highlights the role of interventional radiology in managing complex venous thromboembolic events.

Related Concept Videos

Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
189
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
74
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
79
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
83
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.1K